Literature DB >> 10403720

Hepatitis C and liver transplantation.

M Berenguer1, T L Wright.   

Abstract

Mesh：

Year:  1999        PMID： 10403720      PMCID： PMC1727595          DOI： 10.1136/gut.45.2.159

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  45 in total

1.  Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.

Authors:  T Gayowski; N Singh; I R Marino; H Vargas; M Wagener; C Wannstedt; F Morelli; T Laskus; J J Fung; J Rakela; T E Starzl
Journal:  Transplantation       Date:  1997-08-15       Impact factor: 4.939

2.  Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

Authors:  T Bizollon; U Palazzo; C Ducerf; M Chevallier; M Elliott; J Baulieux; M Pouyet; C Trepo
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

3.  Retransplantation for recurrent hepatitis C.

Authors:  P A Sheiner; L K Schluger; S Emre; S N Thung; J Y Lau; S R Guy; M E Schwartz; C M Miller
Journal:  Liver Transpl Surg       Date:  1997-03

4.  Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

Authors:  H R Rosen; C R Shackleton; L Higa; I M Gralnek; D A Farmer; S V McDiarmid; C Holt; K J Lewin; R W Busuttil; P Martin
Journal:  Am J Gastroenterol       Date:  1997-09       Impact factor: 10.864

5.  Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

Authors:  H R Rosen; S Chou; C L Corless; D R Gretch; K D Flora; A Boudousquie; S L Orloff; J M Rabkin; K G Benner
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

6.  Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

Authors:  V Mazzaferro; E Regalia; A Pulvirenti; A Tagger; S Andreola; M Pasquali; D Baratti; F Romano; U Palazzo; M Zuin; F Bonino; M L Ribero; L Gennari
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

7.  Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.

Authors:  L K Schluger; P A Sheiner; S N Thung; J Y Lau; A Min; D C Wolf; I Fiel; D Zhang; M A Gerber; C M Miller; H C Bodenheimer
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

8.  Long-term outcome of hepatitis C virus infection after liver transplantation.

Authors:  K H Böker; G Dalley; M J Bahr; H Maschek; H L Tillmann; C Trautwein; K Oldhaver; U Bode; R Pichlmayr; M P Manns
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

9.  Graft loss following liver transplantation in patients with chronic hepatitis C.

Authors:  H R Rosen; P M O'Reilly; C R Shackleton; S McDiarmid; C Holt; R W Busuttil; P Martin
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

10.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321
View more
  9 in total

1.  Treatment of hepatitis C infection. Review underplayed important public health issues.

Authors:  K Agarwal; D D Jones
Journal:  BMJ       Date:  1999-08-14

2.  Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1.

Authors:  C Li; D Candotti; J P Allain
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 3.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Performance characteristics of a quantitative, homogeneous TaqMan RT-PCR test for HCV RNA.

Authors:  J Kleiber; T Walter; G Haberhausen; S Tsang; R Babiel; M Rosenstraus
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

5.  Histology predicts cirrhotic evolution of post transplant hepatitis C.

Authors:  M Guido; S Fagiuoli; G Tessari; P Burra; G Leandro; P Boccagni; U Cillo; R Naccarato; M Rugge
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.

Authors:  S C Lee; A Antony; N Lee; J Leibow; J Q Yang; S Soviero; K Gutekunst; M Rosenstraus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Outcome of orthotopic liver transplantation in patients with hepatitis C.

Authors:  Seung W Paik; Henkie P Tan; Andrew S Klein; John K Boitnott; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

8.  Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.

Authors:  Ke-Qin Hu; Huiying Yang; Ying-Chao Lin; Karen L Lindsay; Allan G Redeker
Journal:  Int J Med Sci       Date:  2004-06-01       Impact factor: 3.738

9.  Quality of life 10 years after liver transplantation: The impact of graft histology.

Authors:  Vincent Karam; Mylène Sebagh; Kinan Rifai; Funda Yilmaz; Prashant Bhangui; Colette Danet; Faouzi Saliba; Didier Samuel; Denis Castaing; René Adam; Cyrille Feray
Journal:  World J Transplant       Date:  2016-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.